Skip to Main Content
CWRU Links

October 1, 2015

Dr. Mark Schluchter Stepping Down as Director of the Biostatistics & Bioinformatics Core Facility

Dr. Mark Schluchter, Director of the Biostatistics & Bioinformatics Core Facility (BBCF), is announcing his return to his own research program. Mark is an accomplished biostatistician and professor, and has held an appointment in the CWRU SOM since 1991. He is currently Professor of Epidemiology and Biostatistics, Pediatrics, and General Medical Sciences (Oncology) in the CWRU School of Medicine. Mark served as Associate Director of Biostatistics in the Case CCC from January 2006 to June 2013, and as Director of the Biostatistics & Bioinformatics Core Facility (BBCF) from January 2006 through September 2015. 

During his time as Director of the BBCF for the last nine years, Mark built the BBCF up to be one of the most respected and widely used shared resources in the Case CCC. Via his leadership, he has led a group of over 15 biostatisticians from Case CCC institutions in assisting Cancer Center members with study design, data analysis, data management, and interpretation of results. These critical roles have led to many high impact publications and external grant funding. In addition, he has served as a statistical reviewer for the Protocol Review and Monitoring Committee (PRMC). 

Mark's efforts increased overall use of statistical services in both basic and clinical research areas. His years of counsel to Cancer Center leadership has helped the Center and its members immensely. He also spearheaded the inclusion of Cleveland Clinic biostatistics under the direction of Dr. Paul Elson, and the introduction of bioinformatics into the consultative services of the core. He has improved the quality of statistics used throughout our Cancer Center, and has helped to reduce the instances in which a statistical review had penalized a Cancer Center members' grant review. Mark has also taught our junior faculty statistical design, sample size, and more complex approaches to clinical trial design.

We thank Mark for his service to the Case CCC and for paving the way for future success for the BBCF. We are thrilled that he will continue to be a statistical reviewer for the PRMC.

Please join me in thanking Mark for years of strong advocacy for high quality biostatistics support for all of the research conducted by members of the Case CCC.